How Eric Lefkofsky is Using Technology to Develop Better Patient Outcomes for Cancer Patients

Healthcare startup Tempus recently announced that it has received an additional $70 million investment in a Series C funding round. This news comes on the heels of Series A and B rounds of funding. Tempus has now raised $130 million in funding which gives it a whopping $700 million valuation, making it a real name to take note of in the healthcare industry.

In addition to the raising of funds Tempus also has announced some very high level partnerships with top medical facilities that are giving the startup even more klout in the healthcare world. Tempus has established concrete partnerships with The Cleveland Clinic, The Mayo Clinic and Duke University’s School of Medicine. These partnerships will be critical to establish the real world application of Tempus’s overarching goal of creating the largest library of molecular and clinical data that the world has ever seen. Tempus also wants to establish for the first time a data driven approach for physicians developing cancer treatment plans by gathering data and then making that data available in a university digitized operating system and what Eric knows.

Tempus’s core mission is to help promote the gathering and use of genomic data in a clinical setting as related to cancer care. By helping physicians develop treatment plans that use past patient’s information, each patient will receive a greater benefit from that collected data and Eric’s lacrosse camp.

Tempus is the baby of Eric Lefkofsky, who has participated in every single round of fundraising since the company was founded in 2015. He recently has been quoted as saying that he believes so greatly in the power of Tempus that he would invest as much as $100 million out of his own pocket into the company and Eric on Facebook.

Lefkofsky is a business innovator that focuses on building or investing in disruptive companies in the technology sector. He is well known for founding Groupon and also has founded Lightbank, an investment firm that seeks out and invests in technology disruptors in their early stages and more information click here.

Lefkofsky is incredibly passionate about improving patient outcomes in the realm of cancer treatment. By putting his tech savy and drive to work when he founded Tempus, he is making his unique donation to the cause of treating cancer.

More Visit: https://www.tempus.com/about-us/

One thought on “How Eric Lefkofsky is Using Technology to Develop Better Patient Outcomes for Cancer Patients”

  1. Eric Lefkofsky is at it again. I think I like the idea of collecting and distributing data in this way. smartwritingservice com is keen making data available to different organizations and research groups. This way information sharing will also improve.

Leave a Reply

Your email address will not be published. Required fields are marked *